A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Fixed Doses (50 mg, 100 mg) of Desvenlafaxine Sustained-Release Tablets in Adult Outpatients With Major Depressive Disorder
收藏DataCite Commons2025-07-25 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005332/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the antidepressant efficacy, safety, and tolerability of DVS-SR in subjects receiving daily doses of 50 mg or 100 mg of DVS-SR versus subjects receiving placebo.
提供机构：
Vivli
创建时间：
2020-03-23
